Shu‐Yun Ma

Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma

Jun Cai, Panpan Liu, Huiqiang Huang et al. · Signal Transduction and Targeted Therapy · 2020 · 83 citations · Full text

Medicine, Hematology, Oncology +17

The lncRNA LINC00675 regulates cell proliferation, migration, and invasion by affecting Wnt/β-catenin signaling in cervical cancer

Shu‐Yun Ma, Xiaohong Deng, Yang� Yang et al. · Biomedicine & Pharmacotherapy · 2018 · 61 citations · Full text

Medicine, Molecular Biology, Oncology +17

Sequential <scp>P‐GEMOX</scp> and radiotherapy for early‐stage extranodal natural killer/<scp>T‐</scp>cell lymphoma: A multicenter study

Yuchen Zhang, Shu‐Yun Ma, Jun Cai et al. · American Journal of Hematology · 2021 · 57 citations · Full text

Medicine, Oncology, Radiation Oncology +13

BRD2 induces drug resistance through activation of the RasGRP1/Ras/ERK signaling pathway in adult T‐cell lymphoblastic lymphoma

Xiao‐Peng Tian, Jun Cai, Shu‐Yun Ma et al. · Cancer Communications · 2020 · 52 citations · Full text

Medicine, Cancer Biology, Oncology +17

A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma

Xiao‐Peng Tian, Ning Su, Liang Wang et al. · Clinical Cancer Research · 2020 · 40 citations

Medicine, Biostatistics, Oncology +17